Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s524008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yuyue Qiu und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Food, Southwest Minzu University, Chengdu, Sichuan, 610225, People's Republic of China. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Histones, Drugs, Chinese Herbal, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Histone lactylation, as a common post-translational modification (PTM), is crucial in diseases. Aberrant histone lactylation has been linked to disease pathogenesis, thus positioning it as a therapeutic target. This review summarizes the bidirectional relationship between histone lactylation and diseases, emphasizing how Traditional Chinese medicine (TCM) regulates lactate levels to restore histone lactylation homeostasis. Mechanistically, TCM modulates histone lactylation through dual regulation of lactyltransferases and lactate metabolism, thereby influencing disease progression in inflammatory, metabolic, and neoplastic disorders. Notably, TCM is characterized by unique advantages of cost-effectiveness, high efficacy, and minimal adverse effects. For diseases with established drug resistance, TCM offers a promising therapeutic alternative in managing drug-resistant illness by regulating histone lactylation. This review is conducive to understanding the relationship between histone lactylation and disease. TCM effectively treats diseases through the regulation of histone lactylation, thereby highlighting its potential for disease treatment application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Food, Southwest Minzu University, Chengdu, Sichuan, 610225, People's Republic of China.
Zitieren
APA
Qiu, Y., & Shao, X. (2025). Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s524008
Vancouver
Qiu Y, Shao X. Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s524008
BibTeX
@article{Qiu2025,
author = {Qiu, Yuyue and Shao, Xiaoni},
title = {Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s524008}
}
EUVIMED